Quotient Therapeutics
Pioneering somatic genomics
Cambridge, United States · Founded 2022 · $50.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- quotient-tx.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Series CNov 2023
- Rounds
- 1
About
Flagship Pioneering company pioneering somatic genomics to develop transformative medicines from a new frontier of genetics.
Summary
Quotient Therapeutics is a Biotech company based in Cambridge, United States, founded in 2022. It has raised $50.0M in total across 1 round, most recently a $50.0M Series C round in Nov 2023. Investors include Flagship Pioneering.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2023
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...